Results 121 to 130 of about 3,485 (208)

The Carotid Siphon as a Pulsatility Modulator for Brain Protection: Role of Arterial Calcification Formation. [PDF]

J Pers Med
de Jong PA, Bos D, Koek HL, Deckers PT, Harlianto NI, Ruigrok YM, Spiering W, Zwanenburg J, Mali WPTM.   +8 more
europepmc   +1 more source

Generalized arterial calcifications in a twin recipient treated with etidronate: description of a case report within a narrative review. [PDF]

Arch Med Sci
Corti CG, Nespoli LF, Campari A, Gnan E, Ruscica M, Carugo S.   +5 more
europepmc   +1 more source

Bisphosphonate compliance in Japan from the perspective of product, formulation, and patient characteristics: analysis of medical insurance claim data. [PDF]

J Pharm Health Care Sci
Kabeya K, Satoh H, Yanagi N, Sawada Y.
europepmc   +1 more source

The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose. [PDF]

Osteoporos Int
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM.   +5 more
europepmc   +1 more source

Cervical Diffuse Idiopathic Skeletal Hyperostosis (DISH) as an Underrecognized Cause of Dysphagia: A Case Series and Review of the Literature. [PDF]

Cureus
Laskaratou ED, Sperelakis I, Trygonis N, Dimitriou R, Kontakis G.   +4 more
europepmc   +1 more source

The Bisphosphonate Accumulation Index (BAI): A Quantitative Metric for Cumulative Antiresorptive Exposure in Pre-Procedural Dental and Surgical Assessment. [PDF]

Dent J (Basel)
Zecca PA, Miotto RE, Brusamolino F, Vercellini N, Serafin M, Borgese M.   +5 more
europepmc   +1 more source

Preterm Infant with Generalized Arterial Calcification of Infancy Who Survived Due to Early Diagnosis and Appropriate Treatment with Bisphosphonates: A Case Report. [PDF]

Children (Basel)
Tanaka M, Kobayashi A, Kuwabara H, Nirei J, Ozawa J, Sawano K, Shibata N, Nagasaki K, Saitoh A.   +8 more
europepmc   +1 more source

Osteoporosis medication use over time in the United States and Canada. [PDF]

Osteoporos Int
Hayes KN, Zullo AR, Berry SD, Oganisian A, Aggarwal S, Adegboye M, Cadarette SM.   +6 more
europepmc   +1 more source

Heterotopic ossification (HO) prophylaxis in total hip arthroplasty (THA): A systematic review of level I and level II evidence since 2000. [PDF]

Bone Rep
Puga TB, Box MW, Dieu VM, Marchese CR, Riehl JT.   +4 more
europepmc   +1 more source

Conformational dynamics and asymmetry in multimodal inhibition of membrane-bound pyrophosphatases. [PDF]

Elife
Liu J, Shah A, Liu X, Wort JL, Ma Y, Hardman K, Johansson NG, Ribeiro O, Brookfield A, Bowen A, Yli-Kauhaluoma J, Xhaard H, Jeuken LJC, Goldman A, Pliotas C, Vidilaseris K.   +15 more
europepmc   +1 more source